The Synthesis and Anti-tumour Properties of Poly Ethoxy Ethyl Glycinamide (PEE−G) Scaffolds with Multiple PD-1 Peptides Attached

Abstract

Multivalent structures can provide multiple interactions at a target site and improve binding affinity. The multivalent presentation of the anti-tumour heptapeptide, SNTSESF, was investigated. This peptide's activity has been attributed to blockade of the PD-1 receptor-mediated signalling pathway. Two and four peptide units were conjugated to poly ethoxy ethyl glycinamide (PEE−G) scaffolds to prepare high-purity products. These conjugates and the peptide were examined in a mouse model implanted with GL261 tumours that indicated that presenting more than two copies of peptide SNTSESF on the dendritic scaffold does not increase anti-tumour activity per peptide. The fluorescent labelled peptide and most active multivalent peptide conjugate were therefore screened for their interaction with the human PD−L1 protein in a fluorescence polarisation assay. No indication of a specific SNTSESF peptide/PD−L1 interaction was observed. This finding was further supported by a molecular modelling binding study.